Merck Loses U.K. Appeal Against Teva to Reinstate Cosopt Patent (MRK)

Merck MRK the second-biggest U.S. drug company, lost a U.K. appeal to reinstate its European patent for the glaucoma treatment Cosopt after a successful challenge by Teva Pharmaceutical Industries Ltd.